Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccines in Infectious Diseases Market Overview" report has been added to ResearchAndMarkets.com's offering.
The report provides an assessment of the mRNA vaccines space, including History of mRNA Therapeutics Development, Industry Trends, Marketed Products, Pipeline Product, Opportunities, Challenges, and Unmet Needs, Current Companies and Brief Market Outlook
Messenger RNA (mRNA) is a single-stranded ribonucleic acid that is transcribed from a strand of DNA. mRNA carries the coding information for protein synthesis.
mRNA vaccines use mRNA that correspond to a viral protein, such as a small piece of protein found on the outer membrane, to induce an immune response. The body produces spike proteins triggered by the mRNA which look like the antigens of the viral protein.
Possible advantages of mRNA vaccines include that they have potential to be tested and produced quickly on a large scale, as seen with the mRNA vaccines for COVID-19, resulting in faster distribution to larger numbers of patients.
There are three main therapeutic modalities that utilize mRNA:
- Replacement therapy: mRNA is administered to the patient to compensate for a defective gene/protein or to supply therapeutic proteins
- Vaccination: mRNA encoding specific antigen(s) is administered to elicit protective immunity
- Cell therapy: mRNA is transfected into the cells ex vivo to alter cell phenotype or function, and then these cells are delivered into the patient
This report will focus on mRNA vaccines that are marketed or in development for infectious diseases within the global market. mRNA vaccines in development for other therapy areas are beyond the scope of this report.
Report Scope
- Overview of mRNA vaccinations and history of their therapeutics development
- Current global industry trends together with their opportunities and challenges
- Overview of currently marketed products within the global scope
- Global pipeline analysis
- Overview of leading companies within mRNA vaccines space
- Brief market overview for major mRNA vaccines products
Reasons to Buy
- Understand the trends shaping and driving the mRNA vaccines market
- Identify the innovative technologies and key players leading the mRNA vaccines field
- Recognize gaps and areas of unmet need within the mRNA vaccines market
- Determine the current and future outlook for mRNA vaccines according to key opinion leaders (KOLs)
Key Topics Covered:
- Executive Summary
- mRNA Vaccines Overview
- Industry Trends
- Marketed Products
- Pipeline Products
- Opportunities and Challenges
- Companies
- Market Outlook and Deals
Company Coverage:
- Moderna
- BioNTech
- Pfizer
- Arcturus Therapeutics
- AIM Vaccine Co Ltd
- GSK
- Sanofi
- Novavax
- CSPC Pharmaceutical
- Gennova Biopharmaceutical
- Walvax Biotechnology
- Daiichi Sankyo
- CSL
- Suzhou Abogen
For more information about this report visit https://www.researchandmarkets.com/r/v35dpw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
